NeuroSoV

Description: NeuroSoV develops cutting-edge therapies to slow Parkinson's Disease progression, focusing on oxidative stress targets & preclinical validation for better patient outcomes.

Country: Portugal

Based in: Covilhã

Founded: 2020

Funding Stage: Seed

Tags: ['Parkinson Disease', 'drug development', 'molecules']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.